Progyny Posts Modest Revenue Gain and Sharply Higher Profit in Q2 2026

Improved margins from higher member use with lower stock‑based compensation underpin guidance and ongoing share buybacks that management says bolster renewal visibility for large clients.

Overview

Progyny reported Q2 2026 revenue of $350.5 million and net income of $28.1 million, equal to $0.34 per diluted share.
Non‑GAAP results showed Adjusted EBITDA of $62.1 million and adjusted EPS of $0.55, driven by higher gross profit and reduced stock‑based compensation.
The company added clients and covered lives, reporting 604 employer clients and about 7.185 million average members for the quarter.
Management provided Q3 revenue guidance of $335 million to $345 million and full‑year revenue guidance of $1.36 billion to $1.385 billion with adjusted EPS of $2.04 to $2.10.
Progyny remains debt‑free with strong cash and an undrawn $200 million revolver, and it repurchased nearly 1.2 million shares in Q2 as part of larger buyback programs returning capital to shareholders.